Magellan Pharmacy Services, Inc. $200 Million Term Loan
Davis Polk advised the administrative agent in connection with a $200 million delayed draw term loan facility for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises Aetna on the Sale of Medicare Advantage Assets to Molina Healthcare
Davis Polk is advising Aetna Inc. in connection with the sale by Aetna and Humana Inc. of certain of their respective Medicare Advantage assets to Molina Healthcare, Inc. for a total…
Magellan Pharmacy Services, Inc. $200 Million Term Loan Facility
Davis Polk advised the administrative agent in connection with a $200 million term loan facility (the “Credit Facility”) for Magellan Pharmacy Services, Inc., a wholly owned subsidiary of…
McKesson formation of a new company with Change Healthcare Holdings
Davis Polk advised McKesson Corporation on its creation of a new health care information technology company, which will combine substantially all of Change Healthcare Holdings, Inc.’s…
Davis Polk Advises Verisk Analytics on the Sale of Its Health Care Services Business to Veritas Capital
Davis Polk is advising Verisk Analytics, Inc. in connection with the $820 million sale of Verisk’s health care services business, Verisk Health, to Veritas Capital. The transaction,…
Davis Polk Advises Charles River Laboratories on Its Acquisition of WIL Research
Davis Polk is advising Charles River Laboratories International, Inc. on its acquisition of WIL Research for approximately $585 million. The transaction, which is expected to close early in…
Hologic, Inc. $2.5 Billion Senior Secured Credit Facilities Refinancing
Davis Polk advised the administrative agent in connection with the refinancing of Hologic, Inc.’s existing senior secured credit facilities with a $1.5 billion term loan facility and a $1…